Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology.

about

Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology.

Item

http://www.wikidata.org/entity/Q40108112

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Protocol update and preliminar ...... uropean Society of Cardiology.

@en

type

Item

label

Protocol update and preliminar ...... uropean Society of Cardiology.

@en

prefLabel

Protocol update and preliminar ...... uropean Society of Cardiology.

@en

P1476

Protocol update and preliminar ...... uropean Society of Cardiology.

@en

P2093

Bogdan A Popescu

http://www.w3.org/2001/XMLSchema#string

Chiara Lestuzzi

http://www.w3.org/2001/XMLSchema#string

Ciro Santoro

http://www.w3.org/2001/XMLSchema#string

Dimitrios Farmakis

http://www.w3.org/2001/XMLSchema#string

ESC Cardiac Oncology Toxicity Long-Term Registry Investigators

http://www.w3.org/2001/XMLSchema#string

Erwan Donal

http://www.w3.org/2001/XMLSchema#string

Guy Jerusalem

http://www.w3.org/2001/XMLSchema#string

Marie Moonen

http://www.w3.org/2001/XMLSchema#string

Maryna Andarala

http://www.w3.org/2001/XMLSchema#string

Maurizio Galderisi

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohort

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Adjuvant trastuzumab in HER2-positive breast cancer.

An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicity.

EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.

The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer.

Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.

P304

312-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EHF2.12162

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28772051

http://www.w3.org/2001/XMLSchema#string

P932

5542718

http://www.w3.org/2001/XMLSchema#string